Is Virtus Fund ACV stock maintaining stability Regeneron Pharmaceuticals REGN Otarmeni Gene Therapy Launch Shifts LongTerm Narrative Amid Pipeline Execution Focus CDZIP Cadiz posts wider than expected Q3 2025 loss shares remain flat following quarterly earnings release